Keyphrases
Taiwan
100%
Targeted Therapy
100%
Metastatic Colorectal Cancer (mCRC)
100%
Stage IV Colorectal Cancer
100%
Chemotherapy
57%
L-group
57%
Vascular Endothelial Growth Factor Receptor (VEGFR)
42%
Taiwanese
28%
Cetuximab
28%
Left-sided Tumor
28%
Clinical Practice
14%
Patient Survival
14%
Patient-centered
14%
Overall Survival
14%
Retrospective Observational Study
14%
Cancer Causes
14%
Cancer Mortality
14%
KRAS mutation
14%
Survival Outcomes
14%
Anti-EGFR Therapy
14%
Wild-type KRAS
14%
Progression-free Survival
14%
Median Progression-free Survival
14%
Median Overall Survival
14%
Chemotherapy Alone
14%
Treatment Allocation
14%
Right Colon
14%
Left-sided Colon
14%
Neoadjuvant Setting
14%
Anti-VEGF Therapy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Colorectal Carcinoma
100%
Chemotherapy
71%
Epidermal Growth Factor Receptor
71%
Malignant Neoplasm
28%
Neoplasm
28%
Overall Survival
28%
Cetuximab
28%
Progression Free Survival
28%
Observational Study
14%
Nursing and Health Professions
Colorectal Carcinoma
100%
Vasculotropin
100%
Epidermal Growth Factor Receptor
71%
Malignant Neoplasm
28%
Neoplasm
28%
Overall Survival
28%
Progression Free Survival
28%
Cetuximab
28%
Clinical Practice
14%
Wild Type
14%